Pretreatment with DEX before the induction of general anesthesia (GA) was reported to protect lung cancer patients against lung injury during OLV by upregulating the expression of heme oxygenase-1 and reducing the serum production of TNF-α and reactive oxygen species [97]. This evidence concerns the gene TNF and lung carcinoma.